New Requirement - CE-MS Interface

The contract opportunity pertains to a new requirement for the CE-MS Interface, under the NAICS code 334516, which covers measurement and testing instruments manufacturing. It is a forecast solicitation issued by the Food and Drug Administration (FDA) and was posted on March 11, 2026. The exact location for performance and specific agency office details are not provided. Contact information is available for a program liaison at the FDA, with contracting officer details yet to be determined. This contract likely involves the development, procurement, or enhancement of Capillary Electrophoresis-Mass Spectrometry (CE-MS) technology to support FDA's analytical capabilities. While this forecast does not include set-aside information or detailed scope descriptions, it signals an anticipated opportunity for organizations involved in high-precision instrumentation related to biochemical analysis. Interested parties can reach out to the FDA acquisition liaison via the provided email, and further information may become available as the solicitation progresses. This opportunity aligns with the agency’s ongoing efforts to advance scientific and regulatory technologies essential for public health oversight.